[Long-term outcome in context of intra uterine growth restriction and/or small for gestational age newborns]

G Gascoin1, C Flamant

  • 1Service de réanimation et médecine néonatales, pôle femme-mère-enfant, CHU Angers, 4, rue Larrey, 49933 Angers cedex 9, France.

Insights

Infants born small for gestational age (SGA) or with intra-uterine growth restriction (IUGR) face higher risks of cognitive issues and metabolic syndrome. However, prematurity appears to have a greater impact on long-term outcomes than SGA or IUGR alone.

Area of Science:

  • Pediatrics
  • Neonatology
  • Developmental Biology

Background:

  • Intra-uterine growth restriction (IUGR) and being born small for gestational age (SGA) are significant concerns in neonatal care.
  • Long-term neurodevelopmental and metabolic outcomes for these infants require thorough evaluation.

Purpose of the Study:

  • To systematically review the long-term outcomes for infants with a history of IUGR and/or SGA.
  • To identify associated risks and developmental trajectories.

Main Methods:

  • A systematic evidence review was conducted.
  • Databases searched included PubMed and the Cochrane Library.
  • Expert recommendations were also incorporated.

Main Results:

  • Infants born SGA exhibit increased risks of cognitive deficiencies, attention disorders, and academic difficulties.
  • These individuals are also at higher risk for developing metabolic syndrome in adulthood.
  • While most infants achieve catch-up growth in weight by 6 months and height by 12 months, prematurity shows a more pronounced effect on long-term outcomes than IUGR/SGA alone.

Conclusions:

  • Infants born SGA and/or with IUGR history are predisposed to cognitive and academic challenges, alongside an elevated risk of adult metabolic syndrome.
  • Prematurity significantly influences long-term outcomes, potentially more so than IUGR or SGA status.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
19.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K